Debut Plus

₹40

▼ -0.31 -0.77%

17 Jul 2026

BSE Listed

ESM 1

Sudarshan Pharma Industri (543828)

Volume: 84,000Avg Vol 1W: 2,86,400Avg Vol 1M: 3,91,45552W Range:₹18.5₹42.16
BSE www.sudarshanpharma.com
Key Ratios
Checked just now
Market Cap₹963 Cr
Current Price₹40
Previous Close₹40.31
High / Low (52w)₹42.16 / ₹18.5
Volume84,000
Avg Vol (1W)2,86,400
Avg Vol (1M)3,91,455
Stock P/E41.24
Book Value₹6.44
Dividend Yield0%
ROE15.03%
ROA364.16%
Revenue (TTM)—
Revenue Growth—
Profit Margin331.55%
Total Debt—
Shares Outstanding24 Cr
Face Value—
EPS (TTM)₹0.97
P/B6.21
Debt / Equity1.13
50 DMA₹35.93
200 DMA₹28.34
Day change-0.77%
SurveillanceESM 1 (as of 2026-07-17)
Price Chart
₹40▲ 40.35% · 1Y
₹107₹1920.1L
2025-07-17
2026-07-17

20-day avg volume: 4.0L shares

Pros
  • Healthy return on equity of 15.0%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹99 Cr₹129 Cr₹116 Cr₹162 Cr₹145 Cr₹169 Cr₹168 Cr₹221 Cr
EBITDA₹2 Cr₹13 Cr₹8 Cr₹16 Cr₹11 Cr₹10 Cr₹11 Cr₹23 Cr
Net Profit₹-1 Cr₹6 Cr₹3 Cr₹7 Cr₹4 Cr₹4 Cr₹4 Cr₹11 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹148 Cr₹194 Cr₹358 Cr₹462 Cr₹466 Cr₹508 Cr
EBITDA₹4 Cr₹7 Cr₹11 Cr₹15 Cr₹24 Cr₹40 Cr
Net Profit₹1 Cr₹3 Cr₹5 Cr₹7 Cr₹11 Cr₹16 Cr
EPS1.462.745.465.480.470.66
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹58 Cr₹99 Cr₹138 Cr₹232 Cr₹283 Cr₹402 Cr
Total Liabilities₹38 Cr₹77 Cr₹108 Cr₹132 Cr₹171 Cr₹271 Cr
Equity₹20 Cr₹23 Cr₹30 Cr₹101 Cr₹112 Cr₹131 Cr
Total Debt——————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹1 Cr₹4 Cr₹-2 Cr₹-27 Cr₹10 Cr₹38 Cr
Investing₹-2 Cr₹-1 Cr₹-1 Cr₹-26 Cr₹-7 Cr₹-20 Cr
Financing₹0 Cr₹-1 Cr₹4 Cr₹66 Cr₹-12 Cr₹-14 Cr
Free Cash Flow₹1 Cr₹4 Cr₹-2 Cr₹-27 Cr₹10 Cr₹38 Cr
Shareholding
Promoter 57.39% Institutions 19.95% Public 22.66%
Efficiency & Working Capital
ROCE12.8%
Interest Coverage2.6
Dividend Payout—
Debtor Days116 d
Inventory Days102 d
Payable Days66 d
Cash Conversion Cycle151 d
Working Capital Days217 d
Shareholding Details

As of 2026-03-31

Promoter57.4%
FII19.9%
DII0%
Institutions19.9%
Public22.7%
Promoter Pledge0%
No. of Shareholders1,346
Shareholding Pattern

Quarterly — figures in %. Latest 9 quarters.

PeriodMar 2023Sept 2023Mar 2024Sept 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters57.4%57.4%57.4%57.4%57.4%57.4%57.4%57.4%57.4%
FIIs3.6%1.4%1.4%13.1%18.5%19.5%20.8%19.8%19.9%
DIIs0%0%0%0%0%0%0%0%0%
Public39%41.2%41.2%29.5%24.2%23.1%21.8%22.8%22.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%
No. of Shareholders1,2449839137871,2121,3271,3831,4071,346
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Sachin Vasantrai MehtaShareholding of Promoter and Promoter Group27.5%6.62 Cr
Hemal Vasantrai MehtaShareholding of Promoter and Promoter Group26.6%6.40 Cr
Multitude Growth Funds LimitedPublic Shareholding4.9%1.17 Cr
Century India Opportunity Fund PcPublic Shareholding3.4%82,52,000
Eminence Global Fund Pcc - Eubilia Capital PartnersPublic Shareholding2%48,56,000
Ebisu Global Opportunities Fund LimitedPublic Shareholding2%48,00,000
Nexpact LimitedPublic Shareholding1.9%45,68,000
Coeus Global Opportunities FundPublic Shareholding1.7%41,96,000
North Star Opportunities Fund Vcc - Bull Value IncorPublic Shareholding1.7%41,12,000
Bridge India FundPublic Shareholding1.7%39,80,000
Chaubara Eats Private LimitedPublic Shareholding1%24,92,000
Devangi Hemal MehtaShareholding of Promoter and Promoter Group1%22,94,070
Hemal V Mehta HufShareholding of Promoter and Promoter Group0.7%16,45,120
Namrata Sachin MehtaShareholding of Promoter and Promoter Group0.7%16,45,120
Sachin V Mehta HufShareholding of Promoter and Promoter Group0.7%16,45,120
Vasantray Ratilal MehtaShareholding of Promoter and Promoter Group0.2%4,93,190
Jatin Vasantrai MehtaShareholding of Promoter and Promoter Group0.1%1,64,470
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Vasantray Ratilal Mehta00%2026-03-31
Jatin Vasantrai Mehta00%2026-03-31
Hemal Vasantrai Mehta00%2026-03-31
Devangi Hemal Mehta00%2026-03-31
Hemal V Mehta Huf00%2026-03-31
Sachin Vasantrai Mehta00%2026-03-31
Namrata Sachin Mehta00%2026-03-31
Sachin V Mehta Huf00%2026-03-31
Bridge India Fund00%2026-03-31
Coeus Global Opportunities Fund00%2026-03-31
Ebisu Global Opportunities Fund Limited00%2026-03-31
North Star Opportunities Fund Vcc - Bull Value Incor00%2026-03-31
Board of Directors
NameDesignationYear
Hemal V MehtaCMD & Director.2025
Sachin V MehtaED / Joint MD / CFO / Promoter2025
Umesh LuthraIndependent Non Exe. Director2025
JAYA ANKUR SINGHANIAIndependent Non Exe. Director2025
Rushabh Prashant PatilIndependent Non Exe. Director2025
ANIL BALKRISHNA GHOGARENon-Exec & Non-Independent Dir2025
NIRAV KISHOR KUMAR SHAHCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Chemical Division₹96 Cr68.7%
Pharmaceutical Division₹43 Cr31.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1352424
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025120052138
20254004412
20253002914
Company Information
Incorporated2008
ChairmanHemal V Mehta
AuditorNGST & Associates
Investor Email[email protected]
🌐 www.sudarshanpharma.com ↗

📍 301 3rd Floor Aura Biplex, SV Road Borivali(West), Mumbai, Maharashtra, 400092

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

S. V. J. Enterprises LimitedAmanaya Ventures LimitedResGen LimitedITCONS E-Solutions LimitedDivgi Torqtransfer SystemsProspect Consumer ProductLabelkraft Technologies LimitedBright Outdoor Media LimitedCommand Polymers LimitedDev Labtech Venture LimitedDigital Fibre InfrastructJA Finance LimitedAll “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search